NEW YORK, NY -- May 3, 2016 -- Investors Hub NewsWire – http://www.BroadStreetAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.Broadstreetalerts.com is often on the lookout for large investor awareness campaigns being deployed.
 
To subscribe by phone and receive messages directly to your mobile phone in real time, text keyword "Alerts" to 25827.

Click the link below for the full Due Diligence report.
 
Shares of Cardinal Resources, Inc. (OTCBB: CDNL) jumped 30% in yesterday’s trading session with share volume double the daily average trading 31 million shares. Northwest Biotherapeutics (NASDAQ: NWBO) has issued an update on clinical trials for its DCVax tumor therapy. Paragon Shipping, Inc. (NASDAQ: PRGN) saw share volume increase by a factor of four following information on corporate actions and Amarin Corp. PLC (NASDAQ: AMRN) was up 6% as investors await Q1 results due out on May 5th. Full Report- http://broadstreetalerts.com/dd-amrn-cdnl-nwbo-prgn/
 
 
About Broad Street Alerts
We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Safe Harbor Statement

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements

Compliance Procedure   
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only.  A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.

Source: Broad Street Alerts

Contact: editor@broadstreetalerts.com

 

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Northwest Biotherapeutics (QB) Charts.
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Northwest Biotherapeutics (QB) Charts.